GGrantIndex
Sort

40,608 grants matching prostate cancer

NCI NCTN- Network Lead Academic Participating Site: USC

$523,827
Heinz Josef Lenz · University Of Southern California · U10 · FY2018 · CA

Molecular Mechanisms of Castration Resistant Prostate Cancer Recurrence & Therapeutic Strategies

$523,797
Nupam P Mahajan · Washington University · R01 · FY2019 · CA

Outcomes of Triaged Family Care in Advanced Cancer

$523,527
University Of Michigan At Ann Arbor · R01 · FY2005 · CA

Genetic Epidemiology of Prostate Cancer Risk and Progression

$523,491
John S Witte · University Of California, San Francisco · R01 · FY2013 · CA

Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI

$523,484
Aytekin Oto · University Of Chicago · R01 · FY2022 · CA

Research & Methods Core

$523,415
Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

Northwest Community Clinical Oncology Program

$523,413
Tacoma General Hospital · U10 · FY2004 · CA

Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cells

$523,168
Andrey Kuzmin · Advanced Cytometry Instrumentation Sys · R44 · FY2018 · GM

Role of Shh in developmental patterning and growth of digit skeleton

$523,150
Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer

$523,041
Susan Halabi · Duke University · R01 · FY2024 · CA

Efficacy of a Couple-focused, Tailored, Symptom Self-Management mHealth Intervention for Prostate Cancer Patients and Partners

$523,006
Lixin Song · Univ Of North Carolina Chapel Hill · R01 · FY2019 · NR

Breast &Prostate Cancer &Hormone-related Gene Variants

$523,006
American Cancer Society, Inc. · U01 · FY2004 · CA

Association of inflammatory genes and prostate cancer

$522,927
Wake Forest University Health Sciences · R01 · FY2004 · CA

Colorectal Neoplasia in SELECT Participants

$522,836
M. Peter Lance · University Of Arizona · R01 · FY2010 · CA

Integrated Biochip Sensors for Detection of Cancer

$522,787
Rashid Bashir · University Of Illinois At Urbana-Champaign · R01 · FY2009 · CA

CGEMS

$522,757
Robert Hoover · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

MOX 1--A NOVEL MITOGENIC OXIDASE

$522,752
Emory University · R01 · FY2003 · CA

Integrated Biochip Sensors for Detection of Cancer

$522,748
Rashid Bashir · University Of Illinois At Urbana-Champaign · R01 · FY2010 · CA

Clinical

$522,676
Evan Y-W Yu · Fred Hutchinson Cancer Research Center · P50 · FY2016 · CA

Oncogenic Met Signaling in Urologic Malignancies

$522,479
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor

$522,328
Hua Zhao · University Of Virginia · U01 · FY2023 · CA

KINASE INHIBITORS PRESENT EXCITING THERAPIES FOR CANCER INCLUDING PROSTATE CANCER.

$522,315
University Of Washington · · FY2017 · Department of the Army

Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer

$522,281
Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Accurate MR-based PET Attenuation Correction for Quantitative Clinical Trials

$522,225
Raymond F Muzic · Case Western Reserve University · R01 · FY2018 · CA

Real-time monitoring of circulating pancreatic tumor cells and clusters

$522,167
Erica Carpenter · University Of Pennsylvania · R01 · FY2017 · CA